Pharmacy Report Archives - Page 89 of 150 - Becker's Hospital Review

'Test-to-treat' plan too narrow, pharmacists say | GoodRx to buy pharmacy platform for $150M | 10 places drug spending has jumped most | Ill. hospital on verge of losing license | Confusion over Evusheld leads to low usage

March 7, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. 10 places drug spending has jumped the most since 2010 Full story 2. 'Test-to-treat' program too narrow, pharmacists say Full story 3. GoodRx to acquire pharmacy services platform for $150M Full story…

Civica to launch low-cost insulin | 10 states with highest, lowest Rx costs per household | PeaceHealth partners with 2 pharmacy cos. | What Amazon Care means for hospitals | 10 hospitals seeking pharmacy leaders

March 3, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Civica to manufacture, distribute insulin at discounted price Full story 2. 10 states with the highest, lowest prescription costs per household Full story 3. What does Amazon Care mean for hospitals?…

10 states with most, least Rxs paid out of pocket | US pharmacies to offer free antivirals upon positive COVID test | BA.2 doubling every week | A long wait for CMS' vaccine rule results | Pfizer shot's effectiveness in kids: 7 notes

March 2, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. US unveils 'test to treat' program + 6 more notes from Biden's State of the Union Full story 2. 10 states with biggest, smallest shares of prescriptions paid out of…

Silence on J&J shot leaves recipients with Qs | Moderna faces patent suit | US drug spending up 77% in 10 yrs | Should medical errors be criminalized? | Pfizer vaccine less effective in kids 5-11: study

March 1, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Silence on J&J vaccine leaves recipients with questions Full story 2. Moderna faces patent suit over COVID-19 vaccine Full story 3. 'We can't punish our way to safer medical practices': 2…

Regeneron CEO is most 'overpaid' healthcare chief | FTC's top economist quit 1 day before PBM vote | 8 moves from Walgreens, CVS | Hospital leaders' vaccine exemption worry | A devastating month for hospital finances

February 28, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. FTC's top economist resigned day before PBM vote Full story 2. 17 'overpaid' healthcare CEOs Full story 3. 8 recent moves from Walgreens, CVS Full story 4. 99% of infusion centers…

Cancer drug inventor among healthcare's top 5 billionaires | GSK, Sanofi to seek authorization of COVID shot | 40% of CVS Caremark clients have negative specialty drug trend | Vaccinations lag nationwide | 10 hospitals seeking pharmacy leaders

February 24, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. GlaskoSmithKline, Sanofi report high COVID-19 vaccine efficacy, seek FDA authorization Full story 2. Cancer drug inventor among healthcare's top 5 billionaires Full story 3. 40% of CVS Caremark's PBM clients have…

8 weeks between COVID shots OK for some: CDC | Physicians find limited use for Merck's antiviral | 10 most common sentinel events of 2021 | GSK to spin off consumer healthcare co. | Vaccinations up in 34 states | 5 booster updates

February 23, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. CDC updates vaccine interval guidance Full story 2. Physicians find limited use for Merck's COVID-19 antiviral Full story 3. GSK's consumer healthcare company to be named Haleon Full story 4. In just…

Mark Cuban wants to buck healthcare's status quo | Fortune's 5 most influential drugmakers | CVS launches home health product line | Jazz Pharmaceuticals hit with antitrust suit | Who is getting boosters? 3 notes | BA.2 prevalence, by state

February 22, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Mark Cuban is ready to buck healthcare's status quo Full story 2. CVS launches line of home healthcare products Full story 3. Fortune's 5 most influential drugmakers Full story 4. Some…

U of Utah Health names pharmacy chief | FDA eyes 2nd COVID booster for fall | Family Dollar recalls drugs from rodent-infested facility | 29 burned out specialties, ranked | Community pharmacists decry stalled probe into PBMs

February 21, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. University of Utah Health names chief pharmacy officer Full story 2. FDA considers 2nd COVID-19 booster for fall Full story 3. 5 states with the largest supply of omicron-effective antibody Full story …

Most CVS pharmacies to close for daily lunch breaks | Judge sides with AstraZeneca in 340B dispute | Mich. passes PBM transparency bill | CDC to update mask guidance | Hospitals charge double specialty pharmacy rates for same drugs: AHIP

February 17, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Most CVS pharmacies to close for daily lunch breaks Full story 2. Judge sides with AstraZeneca in 340B dispute Full story 3. Michigan passes pharmacy benefit manager transparency bill Full story 4.…